BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med 2021;21:9. [PMID: 33407290 DOI: 10.1186/s12890-020-01376-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, Wang L, Yu H, Shen Q, Hou Y, Xia YX, Li L, Chang L, Li WH. Irradiated lung cancer cell-derived exosomes modulate macrophage polarization by inhibiting MID1 via miR-4655-5p. Mol Immunol 2023;155:58-68. [PMID: 36709645 DOI: 10.1016/j.molimm.2023.01.009] [Reference Citation Analysis]
2 Gaudreault M, Korte J, Bucknell N, Jackson P, Sakyanun P, McIntosh L, Woon B, Buteau JP, Hofman MS, Mulcahy T, Kron T, Siva S, Hardcastle N. Comparison of dual-energy CT with positron emission tomography for lung perfusion imaging in patients with non-small cell lung cancer. Phys Med Biol 2023;68. [PMID: 36623318 DOI: 10.1088/1361-6560/acb198] [Reference Citation Analysis]
3 Drishya S, Dhanisha SS, Raghukumar P, Guruvayoorappan C. Amomum subulatum mitigates experimental thoracic radiation-induced lung injury by regulating antioxidant status and inflammatory responses. Food Funct 2023. [PMID: 36655677 DOI: 10.1039/d2fo03208b] [Reference Citation Analysis]
4 Lee KY, Shueng PW, Hsu CX. Radiation therapy for oncologic emergencies: The burden or needs for hospitalizations in patients with lung cancer. Am J Emerg Med 2023:S0735-6757(23)00028-1. [PMID: 36681596 DOI: 10.1016/j.ajem.2023.01.024] [Reference Citation Analysis]
5 Son C, Moey MYY, Walker PR, Naqash AR, Peach MS, Ju AW. Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy. Front Oncol 2022;12:1025455. [PMID: 36698405 DOI: 10.3389/fonc.2022.1025455] [Reference Citation Analysis]
6 Bernitsa S, Dayan R, Stephanou A, Tzvetanova ID, Patrikios IS. Natural biomolecules and derivatives as anticancer immunomodulatory agents. Front Immunol 2022;13:1070367. [PMID: 36700235 DOI: 10.3389/fimmu.2022.1070367] [Reference Citation Analysis]
7 Aguado-Barrera ME, Sosa-Fajardo P, Gómez-Caamaño A, Taboada-Valladares B, Couñago F, López-Guerra JL, Vega A. Radiogenomics in lung cancer: Where are we? Lung Cancer 2023;176:56-74. [PMID: 36621035 DOI: 10.1016/j.lungcan.2023.01.001] [Reference Citation Analysis]
8 Rao X, Zhou D, Deng H, Chen Y, Wang J, Zhou X, Jie X, Xu Y, Wu Z, Wang G, Dong X, Zhang S, Meng R, Wu C, Xing S, Fan K, Wu G, Zhou R. Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury. Respir Res 2023;24:25. [PMID: 36694200 DOI: 10.1186/s12931-023-02331-7] [Reference Citation Analysis]
9 Mangesius J, Minasch D, Fink K, Nevinny-Stickel M, Lukas P, Ganswindt U, Seppi T. Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy. Strahlenther Onkol 2023;199:67-77. [PMID: 36515701 DOI: 10.1007/s00066-022-02032-y] [Reference Citation Analysis]
10 Tanaka S, Inoue M, Yamaji T, Iwasaki M, Minami T, Tsugane S, Sawada N, the JPHC Study Group. Increased risk of death from pneumonia among cancer survivors: A propensity score‐matched cohort analysis. Cancer Medicine 2022. [DOI: 10.1002/cam4.5456] [Reference Citation Analysis]
11 Cogno N, Bauer R, Durante M. An Agent-Based Model of Radiation-Induced Lung Fibrosis. Int J Mol Sci 2022;23. [PMID: 36430398 DOI: 10.3390/ijms232213920] [Reference Citation Analysis]
12 Yang IA, Shaw JG, Stephens EK, Chee TM, Duhig EE, Bowman RV, Olive GN, Marshall HM, Fong KM. COPD: the risk of cancer and the impact on cancer care. Lung Diseases and Cancer 2022. [DOI: 10.1183/2312508x.10018721] [Reference Citation Analysis]
13 Karampitsakos T, Sampsonas F, Spagnolo P, Tzouvelekis A. Pulmonary effects of cancer treatments. Lung Diseases and Cancer 2022. [DOI: 10.1183/2312508x.10020421] [Reference Citation Analysis]
14 Tom A. Mulder, Maria L. Andersson, Lucía Peña-Pérez, Kia Heimersson, Ioanna Xagoraris, Björn E. Wahlin, Robert Månsson, Lotta Hansson, Georgios Rassidakis, Marzia Palma. Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment. Hemasphere 2022;6:e794. [PMID: 36325271 DOI: 10.1097/HS9.0000000000000794] [Reference Citation Analysis]
15 Yuan M, Zhao M, Sun X, Hui Z. The mapping of mRNA alterations elucidates the etiology of radiation-induced pulmonary fibrosis. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.999127] [Reference Citation Analysis]
16 Zheng J, Wang Y, Wang Z, Chen W, Luo M, Zhang C, Wang Y, Chen L, Wu F, Yang W, Yang Z, Wang Y, Shi C. Near-infrared Nrf2 activator IR-61 dye alleviates radiation-induced lung injury. Free Radic Res 2022;:1-23. [PMID: 36201846 DOI: 10.1080/10715762.2022.2132942] [Reference Citation Analysis]
17 Käsmann L, Taugner J, Nieto A, Belka C, Eze C, Manapov F. Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic. JCM 2022;11:5713. [DOI: 10.3390/jcm11195713] [Reference Citation Analysis]
18 Zhou C, Yu J. Chinese expert consensus on diagnosis and treatment of radiation pneumonitis. Precision Radiation Oncology 2022. [DOI: 10.1002/pro6.1169] [Reference Citation Analysis]
19 Zhang G, Sun N, Li X. Spleen Tyrosine Kinase Inhibition Mitigates Radiation-induced Lung Injury Through Anti-inflammatory Effects and Downregulation of p38 MAPK and p53.. [DOI: 10.21203/rs.3.rs-2037190/v1] [Reference Citation Analysis]
20 Cotorogea-Simion M, Pavel B, Isac S, Telecan T, Matache IM, Bobirca A, Bobirca FT, Rababoc R, Droc G. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina (Kaunas) 2022;58:1215. [PMID: 36143892 DOI: 10.3390/medicina58091215] [Reference Citation Analysis]
21 Thomas HMT, Hippe DS, Forouzannezhad P, Sasidharan BK, Kinahan PE, Miyaoka RS, Vesselle HJ, Rengan R, Zeng J, Bowen SR. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics? Discov Oncol 2022;13:85. [PMID: 36048266 DOI: 10.1007/s12672-022-00548-4] [Reference Citation Analysis]
22 Li X, Lv F, Wang Y, Du Z. Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia. BMC Pulm Med 2022;22:331. [PMID: 36050683 DOI: 10.1186/s12890-022-02127-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang A, Yang F, Gao L, Shi X, Yang J. Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer. Cancer Manag Res 2022;14:2469-83. [PMID: 35991677 DOI: 10.2147/CMAR.S374648] [Reference Citation Analysis]
24 Sakagami M, Inokuchi H, Mukumoto N, Itoyama H, Hamaura N, Yamagishi M, Mukumoto N, Matsuda S, Shibuya K. Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer.. [DOI: 10.21203/rs.3.rs-1974420/v1] [Reference Citation Analysis]
25 Hao Y, Zhang X, Yu L. Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review. Front Oncol 2022;12:911906. [DOI: 10.3389/fonc.2022.911906] [Reference Citation Analysis]
26 Wiedemann J, Coppes RP, van Luijk P. Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention. Front Oncol 2022;12:931023. [DOI: 10.3389/fonc.2022.931023] [Reference Citation Analysis]
27 Song YQ, Hong J, Wang JY, Peng J, Han JH, Luo HL. Dosimetric comparison of different intensity-modulated radiotherapy techniques for whole-breast irradiation of right-breast cancer. Cancer Radiother 2022:S1278-3218(22)00097-X. [PMID: 35879144 DOI: 10.1016/j.canrad.2022.04.009] [Reference Citation Analysis]
28 He K, Zhang S, Pang J, Yin JC, Mu D, Wang J, Ge H, Ma J, Yang Z, Zheng X, Dong L, Zhang J, Chang P, Li L, Tang S, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan S. Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Front Oncol 2022;12:928605. [DOI: 10.3389/fonc.2022.928605] [Reference Citation Analysis]
29 Arifin AJ, Palma DA. The changing landscape of pneumonitis in non-small cell lung cancer. Lung Cancer 2022;171:1-2. [PMID: 35849898 DOI: 10.1016/j.lungcan.2022.07.008] [Reference Citation Analysis]
30 Deng L, Wang H, Fan T, Chen L, Shi Z, Mi J, Huang W, Wang R, Hu K. Potential Functions of the tRNA-Derived Fragment tRF-Gly-GCC Associated With Oxidative Stress in Radiation-Induced Lung Injury. Dose Response 2022;20:15593258221128744. [PMID: 36176737 DOI: 10.1177/15593258221128744] [Reference Citation Analysis]
31 Zhang Q, Wei Z, Weng H, Chen Y, Zhang J, Mei S, Wei J, Zhu X, Nong Y, Ruan J, Liu W, Zhou R, Wang F, Xie Y, Huang J, Zhang X, Liu F. Folic Acid Preconditioning Alleviated Radiation-Induced Ovarian Dysfunction in Female Mice. Front Nutr 2022;9:854655. [DOI: 10.3389/fnut.2022.854655] [Reference Citation Analysis]
32 Kawanaka Y, Yasuda Y, Tanizaki J, Iwashima D, Nonagase Y, Uemasu K, Hirayama Y, Ogura M, Ozaki T, Takahashi KI. The safety and efficacy of durvalumab consolidation therapy in the management of patients with stage III non-small-cell lung cancer and preexisting interstitial lung disease. Respir Investig 2022:S2212-5345(22)00059-4. [PMID: 35725721 DOI: 10.1016/j.resinv.2022.05.004] [Reference Citation Analysis]
33 Kraus KM, Bauer C, Feuerecker B, Fischer JC, Borm KJ, Bernhardt D, Combs SE. Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose-Volume-Effect Correlation. Cancers (Basel) 2022;14:2948. [PMID: 35740613 DOI: 10.3390/cancers14122948] [Reference Citation Analysis]
34 Yang C, Song C, Wang Y, Zhou W, Zheng W, Zhou H, Deng G, Li H, Xiao W, Yang Z, Kong L, Ge H, Song Y, Sun Y. Re-Du-Ning injection ameliorates radiation-induced pneumonitis and fibrosis by inhibiting AIM2 inflammasome and epithelial-mesenchymal transition. Phytomedicine 2022;102:154184. [PMID: 35665679 DOI: 10.1016/j.phymed.2022.154184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chen T, Zhuang B, Huang Y, Wang W, Jin Y. Inhaled amifostine for the prevention of radiation-induced lung injury. Radiation Medicine and Protection 2022. [DOI: 10.1016/j.radmp.2022.05.001] [Reference Citation Analysis]
36 Chen T, Zhuang B, Huang Y, Liu Y, Yuan B, Wang W, Yuan T, Du L, Jin Y. Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis. Acta Pharm Sin B 2022;12:2522-32. [PMID: 35646537 DOI: 10.1016/j.apsb.2021.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Swain SM, Nishino M, Lancaster LH, Li BT, Nicholson AG, Bartholmai BJ, Naidoo J, Schumacher-Wulf E, Shitara K, Tsurutani J, Conte P, Kato T, Andre F, Powell CA. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management. Cancer Treat Rev 2022;106:102378. [PMID: 35430509 DOI: 10.1016/j.ctrv.2022.102378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
38 Lai GH, Wang F, Nie DR, Lei SJ, Wu ZJ, Cao JX. Identifying Active Substances and the Pharmacological Mechanism of Houttuynia cordata Thunb. in Treating Radiation-Induced Lung Injury Based on Network Pharmacology and Molecular Docking Verification. Evid Based Complement Alternat Med 2022;2022:3776340. [PMID: 35360660 DOI: 10.1155/2022/3776340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Konkol M, Bryl M, Fechner M, Matuszewski K, Śniatała P, Milecki P. Normal Lung Tissue CT Density Changes after Volumetric-Arc Radiotherapy (VMAT) for Lung Cancer. JPM 2022;12:485. [DOI: 10.3390/jpm12030485] [Reference Citation Analysis]
40 Verma S, Dutta A, Dahiya A, Kalra N. Quercetin-3-Rutinoside alleviates radiation-induced lung inflammation and fibrosis via regulation of NF-κB/TGF-β1 signaling. Phytomedicine 2022;99:154004. [PMID: 35219007 DOI: 10.1016/j.phymed.2022.154004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Zhou X, Wang H, Li D, Song N, Yang F, Xu W. MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system. J Cell Mol Med 2022. [PMID: 35088536 DOI: 10.1111/jcmm.17203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Azghadi SF, Daly ME. Radiation Therapy-Induced Lung and Heart Toxicity. Medical Radiology 2022. [DOI: 10.1007/174_2022_336] [Reference Citation Analysis]
43 Venkateswaran K, Verma A, Dwarakanath BS. Polyphenolic Acetates as Potential Therapeutics and Adjuvant in Radiotherapy of Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_38-1] [Reference Citation Analysis]
44 Venkateswaran K, Verma A, Dwarakanath BS. Polyphenolic Acetates as Potential Therapeutics and Adjuvant in Radiotherapy of Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_38] [Reference Citation Analysis]
45 Kok E, Remadevi, Balakrishnan A. Respiratory Prehabilitation in Cancer Surgery. Prehabilitation for Cancer Surgery 2022. [DOI: 10.1007/978-981-16-6494-6_4] [Reference Citation Analysis]
46 Zhang Z, Zhou J, Verma V, Liu X, Wu M, Yu J, Chen D. Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury. Front Immunol 2021;12:774807. [PMID: 34925345 DOI: 10.3389/fimmu.2021.774807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sampson AC, Lassiter BP, Gregory Rivera M, Hair PS, Jackson KG, Enos AI, Vazifedan T, Werner AL, Glesby MJ, Lattanzio FA, Cunnion KM, Krishna NK. Peptide inhibition of acute lung injury in a novel two-hit rat model. PLoS One 2021;16:e0259133. [PMID: 34710157 DOI: 10.1371/journal.pone.0259133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Lotfy DM, Hasan HF, Mostafa DM. Pulmonary prophylactic impact of bee venom against alterations induced by gamma irradiation via TLR4/NF- κB signaling pathway in rats. Toxin Reviews. [DOI: 10.1080/15569543.2021.1988979] [Reference Citation Analysis]
49 Lan K, Xu C, Liu S, Zhu J, Yang Y, Zhang L, Guo S, Xi M. Modeling the risk of radiation pneumonitis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Esophagus 2021;18:861-71. [PMID: 34128129 DOI: 10.1007/s10388-021-00860-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Alem Z, Murray TE, Egri C, Chung J, Liu D, Elsayes KM, Chang SD, Harris A. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3596-614. [PMID: 33909092 DOI: 10.1007/s00261-021-03095-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rahi MS, Parekh J, Pednekar P, Parmar G, Abraham S, Nasir S, Subramaniyam R, Jeyashanmugaraja GP, Gunasekaran K. Radiation-Induced Lung Injury-Current Perspectives and Management. Clin Pract 2021;11:410-29. [PMID: 34287252 DOI: 10.3390/clinpract11030056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
52 Hansel C, Barr S, Schemann AV, Lauber K, Hess J, Unger K, Zitzelsberger H, Jendrossek V, Klein D. Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells. Int J Mol Sci 2021;22:7064. [PMID: 34209135 DOI: 10.3390/ijms22137064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
53 Oshiro Y, Mizumoto M, Sekino Y, Maruo K, Ishida T, Sumiya T, Nakamura M, Ohkawa A, Takizawa D, Okumura T, Tamaki Y, Sakurai H. Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan. Clin Transl Radiat Oncol 2021;29:54-9. [PMID: 34151033 DOI: 10.1016/j.ctro.2021.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Li S, Shao L, Xu T, Jiang X, Yang G, Dong L. An indispensable tool: Exosomes play a role in therapy for radiation damage. Biomed Pharmacother 2021;137:111401. [PMID: 33761615 DOI: 10.1016/j.biopha.2021.111401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]